Think Twice Before Investing in Faster Reg Process for Novel Devices, warns AusBiotech
This article was originally published in Clinica
Executive Summary
Australia's biotech industry association, AusBiotech, has cautioned the government against investing resources in creating a new accelerated pathway for the approval of novel medical devices as this would amount to diverting resources away from making "more desirable" changes to the existing approval pathways.